What are the methods for diagnosing dry eye (keratoconjunctivitis sicca) and related conditions?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Diagnosing dry eye and related conditions involves a comprehensive evaluation, including a thorough medical history, slit-lamp examination, and specialized tests such as the Schirmer test and tear film break-up time assessment 1. The diagnosis of dry eye is typically confirmed by the presence of symptoms, including ocular irritation and blurred vision, in conjunction with objective findings of reduced tear production, often defined as a Schirmer test value of less than 5.5 mm 1.

Diagnostic Tests

  • Aqueous tear production (Schirmer test): measures both basic and reflex tearing, with a value of less than 5.5 mm considered diagnostic of aqueous tear deficiency 1
  • Fluorescein dye disappearance test/tear function index: compares test results with a standard color scale, with less than 10 seconds considered abnormal 1
  • Fluorescein tear break-up time: assesses the stability of the tear film, with a rapid break-up time indicating an unstable tear film 1
  • Ocular surface dye staining: indicates decreased tear lactoferrin concentration, with staining of the inferior cornea and bulbar conjunctiva within the palpebral fissure being typical 1
  • Tear osmolarity: indicates the presence of inflammation, with a cutoff of 312 mOsms/L having 73% sensitivity and 92% specificity for diagnosing dry eye 1
  • Matrix metalloproteinase-9: a point-of-care test that can aid in the diagnosis of dry eye, although it does not differentiate dry eye from other inflammatory ocular surface diseases 1

Classification of Dry Eye Disease

Dry eye disease can be classified into mild, moderate, and severe based on symptoms and signs, with an emphasis on symptoms over signs 1. It can also be categorized into aqueous tear deficiency and evaporative forms, with the majority of patients having a combination of both 1.

Treatment

Treatment may involve the use of artificial tears, such as preservative-free sodium hyaluronate 0.1% or carboxymethylcellulose 0.5%, administered 2-4 times daily, and in severe cases, may require the addition of anti-inflammatory medications, such as loteprednol etabonate 0.5% ophthalmic suspension, dosed 2-4 times daily for a duration of 2-4 weeks 1.

Special Considerations

Patients with dry eye syndrome considering keratorefractive and lens-based surgery should be cautioned that the dry eye symptoms could become worse after surgery, and pre-existing factors contributing to dry eye syndrome should be improved preoperatively to reduce the chance of worsened dry eye syndrome 1. Approximately 10% of patients with clinically aqueous tear deficiency dry eye have underlying Sjögren’s syndrome, which should be suspected if intrinsic tear-production deficiency is detected in nonelderly women, especially if it is rapid in onset and/or marked in severity 1.

From the Research

Diagnostic Methods for Dry Eye

  • Slit-lamp-based techniques, such as direct palpebral lobe and tear flow assessment, Schirmer test, meibum quality and expressibility, and evaluation of tear meniscus height, can be used to diagnose dry eye disease (DED) 2
  • Non-invasive tear meniscus height (TMH), tear break-up time (TBUT), lipid layer thickness (LLT), and meibography are machine-based diagnostic tests that can be used to evaluate DED 2
  • The recommended sequence of tests for diagnosing DED is a dry eye questionnaire, TMH, LLT, NIBUT (FBUT if non-invasive test is unavailable but should be performed after osmolarity), tear osmolarity, meibography, and ocular surface staining 2
  • Blinking tolerance time (BTT) is a new diagnostic test that can be used for self-evaluation of tear-film stability, and it has been validated against the tBUT test 3

Evaluation of Tear-Producing Glands

  • The structure-function correlation of the tear-producing glands gives more comprehensive details than either information alone 2
  • Meibography can be used to evaluate the meibomian glands, and it is a non-invasive diagnostic test 2
  • Schirmer test can be used to evaluate the lacrimal gland function, but it is an invasive test and should be performed after non-invasive tear film diagnostic testing 2

Other Diagnostic Tests

  • Ocular Surface Disease Index questionnaire can be used to evaluate dry eye-related symptoms 3, 4
  • Corneal and conjunctival staining can be used to evaluate the ocular surface damage in patients with dry eye 5, 4
  • Tear film break-up time (TF-BUT) can be used to evaluate the tear film stability 4

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.